Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise
Canagliflozin is a sodium glucose co-transporter 2 inhibitor in development for type 2 diabetes mellitus (T2DM). The efficacy and safety of canagliflozin were evaluated in subjects with T2DM inadequately controlled with diet and exercise.In this 26-week, randomized, double-blind, placebo-controlled,...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | 英語 |
| 出版事項: |
2012
|
| オンライン･アクセス: | https://doi.org/10.1111/dom.12054 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|